These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 3307403

  • 1. Effects of short-term insulin therapy upon therapeutic response to glipizide.
    Schwartz SL, Fischer JS, Kipnes MS, Boyle M.
    Am J Med; 1987 Sep 18; 83(3A):22-30. PubMed ID: 3307403
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of first-generation sulfonylureas and glipizide in non-insulin-dependent diabetes mellitus.
    Beisswenger PJ, Dias N, Beckman F.
    Am J Med; 1987 Sep 18; 83(3A):16-21. PubMed ID: 3631118
    [Abstract] [Full Text] [Related]

  • 3. Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.
    Rosenstock J, Meisel A, Raskin P.
    Am J Med; 1987 Sep 18; 83(3A):10-5. PubMed ID: 3307402
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
    Simonson DC, Kourides IA, Feinglos M, Shamoon H, Fischette CT.
    Diabetes Care; 1997 Apr 18; 20(4):597-606. PubMed ID: 9096986
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.
    Berelowitz M, Fischette C, Cefalu W, Schade DS, Sutfin T, Kourides IA.
    Diabetes Care; 1994 Dec 18; 17(12):1460-4. PubMed ID: 7882817
    [Abstract] [Full Text] [Related]

  • 6. Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
    Simpson HC, Sturley R, Stirling CA, Reckless JP.
    Diabet Med; 1990 Feb 18; 7(2):143-7. PubMed ID: 2137755
    [Abstract] [Full Text] [Related]

  • 7. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
    Lev JD, Zeidler A, Kumar D.
    Diabetes Care; 1987 Feb 18; 10(6):679-82. PubMed ID: 3123183
    [Abstract] [Full Text] [Related]

  • 8. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
    Goldstein BJ, Pans M, Rubin CJ.
    Clin Ther; 2003 Mar 18; 25(3):890-903. PubMed ID: 12852706
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of glipizide treatment on various aspects of glucose, insulin, and lipid metabolism in patients with noninsulin-dependent diabetes mellitus.
    Reaven GM.
    Am J Med; 1983 Nov 30; 75(5B):8-14. PubMed ID: 6369970
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The combined use of insulin and sulfonylurea therapy in patients with non-insulin dependent diabetes mellitus.
    Reaven GM, Fraze E, Chen NY, Hollenbeck C, Chen YD.
    Horm Metab Res; 1989 Mar 30; 21(3):132-6. PubMed ID: 2663691
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.
    Groop L, Groop PH, Stenman S, Saloranta C, Tötterman KJ, Fyhrquist F, Melander A.
    Diabetes Care; 1987 Mar 30; 10(6):671-8. PubMed ID: 3123184
    [Abstract] [Full Text] [Related]

  • 15. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.
    Osei K, O'Dorisio TM, Falko JM.
    Am J Med; 1984 Dec 30; 77(6):1002-9. PubMed ID: 6439036
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC, Tsang LW, Sorensen JP, Cockram CS.
    Diabetes Care; 1995 Mar 30; 18(3):307-14. PubMed ID: 7555472
    [Abstract] [Full Text] [Related]

  • 18. The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.
    Bitzén PO, Melander A, Scherstén B, Wåhlin-Boll E.
    Eur J Clin Pharmacol; 1988 Mar 30; 35(1):31-7. PubMed ID: 3065086
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Benefits and risks with glyburide and glipizide in elderly NIDDM patients.
    Brodows RG.
    Diabetes Care; 1992 Jan 30; 15(1):75-80. PubMed ID: 1737544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.